Your browser doesn't support javascript.
loading
Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C.
Maddux, Aline B; Young, Cameron C; Kucukak, Suden; Zambrano, Laura D; Newhams, Margaret M; Rollins, Caitlin K; Halasa, Natasha B; Gertz, Shira J; Mack, Elizabeth H; Schwartz, Stephanie; Kong, Michele; Loftis, Laura L; Irby, Katherine; Rowan, Courtney M; Tarquinio, Keiko M; Zinter, Matt S; Crandall, Hillary; Cvijanovich, Natalie Z; Schuster, Jennifer E; Fitzgerald, Julie C; Staat, Mary A; Hobbs, Charlotte V; Nofziger, Ryan A; Shein, Steven; Flori, Heidi; Cullimore, Melissa L; Chatani, Brandon M; Levy, Emily R; Typpo, Katri V; Hume, Janet R; Campbell, Angela P; Randolph, Adrienne G.
Affiliation
  • Maddux AB; Section of Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, United States.
  • Young CC; Critical Care, and Pain Medicine, Department of Anesthesiology, Boston Children's Hospital, Boston, MA, United States.
  • Kucukak S; Critical Care, and Pain Medicine, Department of Anesthesiology, Boston Children's Hospital, Boston, MA, United States.
  • Zambrano LD; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Newhams MM; Critical Care, and Pain Medicine, Department of Anesthesiology, Boston Children's Hospital, Boston, MA, United States.
  • Rollins CK; Departments of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, MA, United States.
  • Halasa NB; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Gertz SJ; Division of Pediatric Critical Care, Department of Pediatrics, Cooperman Barnabas Medical Center, Livingston, NJ, United States.
  • Mack EH; Division of Pediatric Critical Care Medicine, Medical University of South Carolina, Charleston, SC, United States.
  • Schwartz S; Department of Pediatrics, University of North Carolina at Chapel Hill Children's Hospital, Chapel Hill, NC, United States.
  • Kong M; Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Loftis LL; Section of Critical Care Medicine, Department of Pediatrics, Texas Children's Hospital, Houston, TX, United States.
  • Irby K; Section of Pediatric Critical Care, Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR, United States.
  • Rowan CM; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Tarquinio KM; Division of Critical Care Medicine, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States.
  • Zinter MS; Department of Pediatrics, Division of Critical Care, University of California San Francisco, San Francisco, CA, United States.
  • Crandall H; Division of Pediatric Critical Care, Department of Pediatrics, Primary Children's Hospital, University of Utah, Salt Lake City, UT, United States.
  • Cvijanovich NZ; Division of Critical Care Medicine, UCSF Benioff Children's Hospital, Oakland, CA, United States.
  • Schuster JE; Division of Pediatric Infectious Disease, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, MO, United States.
  • Fitzgerald JC; Department of Anesthesiology and Critical Care, Perelman School of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States.
  • Staat MA; Department of Pediatrics, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, United States.
  • Hobbs CV; Division of Infectious Diseases, Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS, United States.
  • Nofziger RA; Division of Critical Care Medicine, Akron Children's Hospital, Akron, OH, United States.
  • Shein S; Division of Pediatric Critical Care Medicine, Rainbow Babies and Children's Hospital, Cleveland, OH, United States.
  • Flori H; Division of Pediatric Critical Care Medicine, Department of Pediatrics, C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, MI, United States.
  • Cullimore ML; Division of Pediatric Critical Care, Department of Pediatrics, Children's Hospital and Medical Center, Omaha, NE, United States.
  • Chatani BM; Division of Pediatric Infectious Disease, Department of Pediatrics, AdventHealth for Children, Orlando, FL, United States.
  • Levy ER; Division of Pediatric Infectious Diseases, Division of Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States.
  • Typpo KV; Diamond Children's Banner Children's Medical Center, University of Arizona, Tucson, AZ, United States.
  • Hume JR; Division of Pediatric Critical Care, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, United States.
  • Campbell AP; COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Randolph AG; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, United States.
Front Pediatr ; 11: 1260372, 2023.
Article in En | MEDLINE | ID: mdl-37920792
Objective: To identify risk factors for persistent impairments after pediatric hospitalization for acute coronavirus disease 2019 (COVID-19) or multisystem inflammatory syndrome in children (MIS-C) during the SARS-CoV-2 pandemic. Methods: Across 25 U.S. Overcoming COVID-19 Network hospitals, we conducted a prospective cohort study of patients <21-years-old hospitalized for acute COVID-19 or MIS-C (May 2020 to March 2022) surveyed 2- to 4-months post-admission. Multivariable regression was used to calculate adjusted risk ratios (aRR) and 95% confidence intervals (CI). Results: Of 232 children with acute COVID-19, 71 (30.6%) had persistent symptoms and 50 (21.6%) had activity impairments at follow-up; for MIS-C (n = 241), 56 (23.2%) had persistent symptoms and 58 (24.1%) had activity impairments. In adjusted analyses of patients with acute COVID-19, receipt of mechanical ventilation was associated with persistent symptoms [aRR 1.83 (95% CI: 1.07, 3.13)] whereas obesity [aRR 2.18 (95% CI: 1.05, 4.51)] and greater organ system involvement [aRR 1.35 (95% CI: 1.13, 1.61)] were associated with activity impairment. For patients with MIS-C, having a pre-existing respiratory condition was associated with persistent symptoms [aRR 3.04 (95% CI: 1.70, 5.41)] whereas obesity [aRR 1.86 (95% CI: 1.09, 3.15)] and greater organ system involvement [aRR 1.26 (1.00, 1.58)] were associated with activity impairments. Discussion: Among patients hospitalized, nearly one in three hospitalized with acute COVID-19 and one in four hospitalized with MIS-C had persistent impairments for ≥2 months post-hospitalization. Persistent impairments were associated with more severe illness and underlying health conditions, identifying populations to target for follow-up.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pediatr Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pediatr Year: 2023 Document type: Article